Dr. Iftach Dolev, a neuroscientist and CEO of QuantalX, explained how his company’s new FDA-cleared de novo device can bring a powerful tool to psychiatrists and neurologists alike. He claims this marks an important moment for brain health.
The post MedCity Pivot Podcast: Could This Device Make Managing Brain Health Easier? appeared first on MedCity News.
